{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/724-US10,975,364(Active) re (Done on website already).pdf"}, "page_content": "20. The method of claim 11, wherein the mutation amino acid substitution.\n\n9. The modified protein of claim 8, wherein the one sites are off-target sites on the target DNA molecule.\n\n21. A kit comprising a modified Streptococcus aureus Cas9 protein with a mutation at an N413 position, and optionally one or more of a nuclear localization sequence, a cell penetrating peptide sequence, an affinity tag or a fusion base editor protein, wherein the modified protein comprises the amino acid sequence selected from SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4 or a homologue thereof having at least 90% overall sequence identity to the amino acid sequence.\n\n10. The modified protein of claim 1, wherein the mutation a single amino acid substitution.\n\n11. An in vitro method for altering the genome of an isolated host cell, the method comprising the step of using modified Streptococcus aureus Cas9 protein with a muta- tion at an N413 position, and optionally one or more of nuclear localization sequence, a cell penetrating peptide\n\n3.\n\n4.\n\na\n\nor\n\nmore\n\nis\n\na\n\na\n\n30\n\n35\n\n40\n\n45\n\n50\n\n35\n\n60\n\n65\n\nis\n\nthe\n\nprotein\n\nprotein\n\nor\n\nprotein\n\ncomprises\n\nand.\n\nis a\n\nsingle\n\nUS 10,975,364 B2\n\n94\n\n93\n\n22. The kit of claim 21 , wherein the modified protein\n\ncomprises the amino acid sequence of SEQ ID NO : 1 .\n\n23. The kit of claim 22 , wherein the modified protein\n\ncomprises the amino acid sequence of SEQ ID NO : 2 .\n\n24. The kit of claim 21 , the modified protein further 5\n\ncomprising one or more mutations at R245 , N419 or R654\n\npositions .\n\n25. The kit of claim 23 , the modified protein further\n\ncomprising one or more mutations at R245 , N419 and R654\n\npositions .\n\n10\n\n26. The kit of claim 23 , wherein the modified protein\n\ncomprises the amino acid sequence of SEQ ID NO : 3 .\n\n27. The kit of claim 23 , wherein the modified protein\n\ncomprises the amino acid sequence of SEQ ID NO : 4 .\n\n28. The kit of claim 23 , wherein the modified protein 15", "type": "Document"}}